176 related articles for article (PubMed ID: 1303691)
1. Antibacterial in vitro-activity of meropenem against 200 clinical isolates in comparison to 11 selected antibiotics.
Lang C; Beuth J; Ko HL; Tunggal L; Pulverer G
Zentralbl Bakteriol; 1992 Dec; 277(4):485-92. PubMed ID: 1303691
[TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of meropenem compared to nine other antimicrobial agents: importance of its stability when used in agar dilution systems.
Mudaliar UA; Furyk NI; Moritz VA; Mayall BC
Pathology; 1996 Nov; 28(4):352-5. PubMed ID: 9007956
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of meropenem against clinical isolates obtained in Canada.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216
[TBL] [Abstract][Full Text] [Related]
6. Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom.
King A; Boothman C; Phillips I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():31-45. PubMed ID: 2808214
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
Sader HS; Jones RN
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):384-91. PubMed ID: 8354307
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I.
Edwards JR; Turner PJ; Wannop C; Withnell ES; Grindey AJ; Nairn K
Antimicrob Agents Chemother; 1989 Feb; 33(2):215-22. PubMed ID: 2655530
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Joly-Guillou ML; Kempf M; Cavallo JD; Chomarat M; Dubreuil L; Maugein J; Muller-Serieys C; Roussel-Delvallez M
BMC Infect Dis; 2010 Mar; 10():72. PubMed ID: 20298555
[TBL] [Abstract][Full Text] [Related]
10. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
Watt B; Naden M
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolates.
Ravizzola G; Pinsi G; Gonzales R; Colombrita D; Pirali F; Turano A
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1053-61. PubMed ID: 2620673
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers.
Pitkin DH; Sheikh W; Nadler HL
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S238-48. PubMed ID: 9126699
[TBL] [Abstract][Full Text] [Related]
13. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
Edwards JR
New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T
Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
Visser MR; Hoepelman IM; Beumer H; Rozenberg-Arska M; Verhoef J
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1061-4. PubMed ID: 2695328
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers.
Sheikh W; Pitkin DH; Nadler H
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S361-6. PubMed ID: 8324148
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem.
Di Modugno E; Broggio R; Erbetti I; Lowther J
Antimicrob Agents Chemother; 1997 Dec; 41(12):2742-8. PubMed ID: 9420050
[TBL] [Abstract][Full Text] [Related]
18. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.
Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):157-63. PubMed ID: 9327242
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of anaerobic bacteria to meropenem.
Nord CE; Lindmark A; Persson I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():113-7. PubMed ID: 2553656
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia.
García-Rodríguez JA; García Sánchez JE; Muñoz Bellido JL; García Sánchez E; García García MI
J Chemother; 1991 Jun; 3(3):143-6. PubMed ID: 1919651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
